|
MediWound Ltd. (MDWD) DCF -Bewertung
IL | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
MediWound Ltd. (MDWD) Bundle
Unabhängig davon, ob Sie ein Investor oder Analyst sind, ist dieser (MDWD) DCF-Taschenrechner Ihre Anlaufstelle für eine genaue Bewertung. Ausgestattet mit echten Daten von MediWound Ltd. können Sie Prognosen anpassen und die Auswirkungen sofort beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31.8 | 21.8 | 23.8 | 26.5 | 18.7 | 16.8 | 15.1 | 13.6 | 12.2 | 11.0 |
| Revenue Growth, % | 0 | -31.54 | 9.19 | 11.5 | -29.48 | -10.08 | -10.08 | -10.08 | -10.08 | -10.08 |
| EBITDA | 3.4 | -7.8 | -11.2 | -18.1 | -4.9 | -5.6 | -5.0 | -4.5 | -4.1 | -3.7 |
| EBITDA, % | 10.77 | -35.61 | -47.22 | -68.27 | -26.19 | -33.3 | -33.3 | -33.3 | -33.3 | -33.3 |
| Depreciation | 1.2 | 1.1 | 1.2 | 1.3 | 1.3 | .9 | .8 | .7 | .6 | .6 |
| Depreciation, % | 3.62 | 5.01 | 5.21 | 4.8 | 6.97 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
| EBIT | 2.3 | -8.8 | -12.5 | -19.4 | -6.2 | -6.5 | -5.8 | -5.2 | -4.7 | -4.2 |
| EBIT, % | 7.15 | -40.62 | -52.43 | -73.06 | -33.16 | -38.42 | -38.42 | -38.42 | -38.42 | -38.42 |
| Total Cash | 29.5 | 21.6 | 11.0 | 33.9 | 41.5 | 14.7 | 13.2 | 11.9 | 10.7 | 9.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.1 | 2.8 | 2.3 | 9.3 | 4.4 | 3.2 | 2.8 | 2.6 | 2.3 | 2.1 |
| Account Receivables, % | 12.92 | 12.71 | 9.54 | 35.22 | 23.65 | 18.81 | 18.81 | 18.81 | 18.81 | 18.81 |
| Inventories | 1.6 | 1.4 | 1.2 | 2.0 | 2.8 | 1.3 | 1.2 | 1.1 | 1.0 | .9 |
| Inventories, % | 5.07 | 6.34 | 5.05 | 7.41 | 15.23 | 7.82 | 7.82 | 7.82 | 7.82 | 7.82 |
| Accounts Payable | 4.1 | 3.0 | 4.7 | 5.7 | 5.5 | 3.3 | 2.9 | 2.6 | 2.4 | 2.1 |
| Accounts Payable, % | 12.79 | 13.75 | 19.75 | 21.35 | 29.58 | 19.44 | 19.44 | 19.44 | 19.44 | 19.44 |
| Capital Expenditure | -.8 | -.9 | -.5 | -.6 | -6.5 | -1.5 | -1.4 | -1.2 | -1.1 | -1.0 |
| Capital Expenditure, % | -2.49 | -4.24 | -2.06 | -2.09 | -34.59 | -9.1 | -9.1 | -9.1 | -9.1 | -9.1 |
| Tax Rate, % | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 | -2.83 |
| EBITAT | 4.1 | -9.1 | -12.5 | -19.4 | -6.4 | -6.5 | -5.8 | -5.2 | -4.7 | -4.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 2.8 | -8.5 | -9.4 | -25.6 | -7.6 | -6.6 | -6.3 | -5.7 | -5.1 | -4.6 |
| WACC, % | 7.81 | 7.81 | 7.81 | 7.81 | 7.81 | 7.81 | 7.81 | 7.81 | 7.81 | 7.81 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -22.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -5 | |||||||||
| Terminal Value | -80 | |||||||||
| Present Terminal Value | -55 | |||||||||
| Enterprise Value | -78 | |||||||||
| Net Debt | -6 | |||||||||
| Equity Value | -73 | |||||||||
| Diluted Shares Outstanding, MM | 9 | |||||||||
| Equity Value Per Share | -8.05 |
What You Will Get
- Comprehensive MDWD Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess MediWound's future performance.
- User-Friendly Design: Designed for professionals while remaining accessible for newcomers.
Key Features
- Comprehensive Data: MediWound Ltd.'s historical financial records and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: View MediWound Ltd.'s intrinsic value update instantly.
- Dynamic Visuals: Dashboard graphs showcase valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool for analysts, investors, and finance professionals.
How It Works
- 1. Access the Template: Download and open the Excel file featuring MediWound Ltd.'s (MDWD) financial data.
- 2. Adjust Key Inputs: Modify essential parameters such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results in Real-Time: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Different Scenarios: Evaluate various forecasts to assess different valuation possibilities.
- 5. Present with Assurance: Deliver professional valuation analyses to inform your strategic decisions.
Why Choose This Calculator for MediWound Ltd. (MDWD)?
- Accurate Data: Utilize real MediWound financials for dependable valuation outcomes.
- Customizable: Tailor key inputs such as growth projections, discount rates, and tax assumptions to fit your analysis.
- Time-Saving: Pre-configured calculations streamline the process, eliminating the need to build from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and healthcare consultants.
- User-Friendly: An intuitive design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Individual Investors: Gain insights to make informed decisions about buying or selling MediWound Ltd. (MDWD) stock.
- Financial Analysts: Enhance valuation processes with comprehensive financial models tailored for MediWound Ltd. (MDWD).
- Consultants: Provide clients with accurate and timely valuation insights related to MediWound Ltd. (MDWD).
- Business Owners: Learn how companies like MediWound Ltd. (MDWD) are valued to inform your own business strategy.
- Finance Students: Explore real-world data and scenarios to master valuation techniques relevant to MediWound Ltd. (MDWD).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled MediWound Ltd. (MDWD) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), featuring parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models illustrating intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for MediWound Ltd. (MDWD).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to simplify result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.